BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9304827)

  • 1. Postmortem serum and tissue redistribution of fluoxetine and norfluoxetine in dogs following oral administration of fluoxetine hydrochloride (Prozac).
    Pohland RC; Bernhard NR
    J Forensic Sci; 1997 Sep; 42(5):812-6. PubMed ID: 9304827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmortem redistribution of olanzapine following intramuscular administration of olanzapine pamoate in dogs.
    Johnson JT; Everly AG; Kpakima FEF; Detke HC
    Forensic Sci Int; 2015 Dec; 257():353-358. PubMed ID: 26517823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extent of postmortem drug redistribution in a rat model.
    Hilberg T; Ripel A; Slørdal L; Bjørneboe A; Mørland J
    J Forensic Sci; 1999 Sep; 44(5):956-62. PubMed ID: 10486948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of fluoxetine in rhesus macaques following multiple routes of administration.
    Sawyer EK; Howell LL
    Pharmacology; 2011; 88(1-2):44-9. PubMed ID: 21757974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmortem release of amitriptyline from the lungs; a mechanism of postmortem drug redistribution.
    Hilberg T; Mørland J; Bjørneboe A
    Forensic Sci Int; 1994 Jan; 64(1):47-55. PubMed ID: 8157229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red cell and plasma concentrations of fluoxetine and norfluoxetine.
    Amitai Y; Kennedy E; DeSandre P; Fawcett J; Frischer H
    Vet Hum Toxicol; 1993 Apr; 35(2):134-6. PubMed ID: 8470355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk.
    Hendrick V; Stowe ZN; Altshuler LL; Mintz J; Hwang S; Hostetter A; Suri R; Leight K; Fukuchi A
    Biol Psychiatry; 2001 Nov; 50(10):775-82. PubMed ID: 11720696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ratio of plasma fluoxetine to norfluoxetine concentrations and associated sedation.
    Keck PE; McElroy SL
    J Clin Psychiatry; 1992 Apr; 53(4):127-9. PubMed ID: 1564047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and electrocardiographic effects of fluoxetine and its major metabolite, norfluoxetine, in anesthetized dogs.
    Steinberg MI; Smallwood JK; Holland DR; Bymaster FP; Bemis KG
    Toxicol Appl Pharmacol; 1986 Jan; 82(1):70-9. PubMed ID: 3484846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of norfluoxetine in the inhibition of desipramine metabolism and in the inhibition of serotonin uptake after fluoxetine administration to rats.
    Fuller RW; Snoddy HD
    Res Commun Chem Pathol Pharmacol; 1991 Jul; 73(1):31-40. PubMed ID: 1715593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicokinetics, disposition and metabolism of fluoxetine in crabs.
    Robert A; Schultz IR; Hucher N; Monsinjon T; Knigge T
    Chemosphere; 2017 Nov; 186():958-967. PubMed ID: 28830067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental transfer and fetal distribution of fluoxetine in the rat.
    Pohland RC; Byrd TK; Hamilton M; Koons JR
    Toxicol Appl Pharmacol; 1989 Apr; 98(2):198-205. PubMed ID: 2785300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study.
    Amsterdam JD; Fawcett J; Quitkin FM; Reimherr FW; Rosenbaum JF; Michelson D; Hornig-Rohan M; Beasley CM
    Am J Psychiatry; 1997 Jul; 154(7):963-9. PubMed ID: 9210747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine hydrochloride (Prozac) toxicity in a neonate.
    Spencer MJ
    Pediatrics; 1993 Nov; 92(5):721-2. PubMed ID: 8414864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of norfluoxetine in rats: Increasing extracellular serotonin level in the frontal cortex.
    Qu Y; Aluisio L; Lord B; Boggs J; Hoey K; Mazur C; Lovenberg T
    Pharmacol Biochem Behav; 2009 May; 92(3):469-73. PubMed ID: 19463261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the antidepressant fluoxetine and its metabolite norfluoxetine in serum by reversed-phase HPLC with ultraviolet detection.
    Orsulak PJ; Kenney JT; Debus JR; Crowley G; Wittman PD
    Clin Chem; 1988 Sep; 34(9):1875-8. PubMed ID: 3262022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The distribution of fluoxetine in human fluids and tissues.
    Johnson RD; Lewis RJ; Angier MK
    J Anal Toxicol; 2007 Sep; 31(7):409-14. PubMed ID: 17725889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An animal model of postmortem amitriptyline redistribution.
    Hilberg T; Bugge A; Beylich KM; Ingum J; Bjørneboe A; Mørland J
    J Forensic Sci; 1993 Jan; 38(1):81-90. PubMed ID: 8426162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of renal and hepatic disease on the pharmacokinetics, renal tolerance, and risk-benefit profile of fluoxetine.
    Bergstrom RF; Beasley CM; Levy NB; Blumenfield M; Lemberger L
    Int Clin Psychopharmacol; 1993; 8(4):261-6. PubMed ID: 8277145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anorectic activity of fluoxetine and norfluoxetine in mice, rats and guinea-pigs.
    Anelli M; Bizzi A; Caccia S; Codegoni AM; Fracasso C; Garattini S
    J Pharm Pharmacol; 1992 Aug; 44(8):696-8. PubMed ID: 1359101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.